COCAINE USE AND HETEROSEXUAL EXPOSURE TO HUMAN-IMMUNODEFICIENCY-VIRUS

被引：16

作者：

LARRAT, EP

ZIERLER, S

MAYER, K

机构：

[1] Department of Community Health, Brown University School of Medicine, Providence, RI

[2] Department of Pharmacy Practice, University of Rhode Island College of Pharmacy, Kingston, RI

[3] Providence, RI

[4] Infectious Disease Division, The Memorial Hospital, Pawtucket, RI

来源：

EPIDEMIOLOGY | 1994年 / 5卷 / 04期

关键词：

ACQUIRED IMMUNODEFICIENCY SYNDROME; HIV DISEASE; COCAINE; BEHAVIOR;

D O I：

10.1097/00001648-199407000-00004

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

We examined the relation between recent cocaine use and heterosexual exposure to human immunodeficiency virus (HIV). Five hundred nineteen heterosexually active participants in the New England Behavioral Health Study, an HN resting and counseling program, provided information for this study. The outcome measure included behaviors that increased the risk for exposure to HIV via contact with infected genital secretions. Nearly one third (31.8%) of participants reported use of cocaine during the year before study entry. These individuals were 1.3 times [90% confidence interval (CI) = 1.1-1.7] more likely to risk HIV exposure than people not using cocaine during this period, with evidence of a dose dependent relation among HN positive cocaine users. HIV positive crack users were at 1.9 times greater risk (90% CI = 2.2-2.9) for HIV risk taking behavior than those who did not use crack. The effect of cocaine was present even among those individuals without other injection drug use.

引用

页码：398 / 403

页数：6

共 32 条

[1]

National Household Survey on Drug Abuse: Highlights 1990, (1991)

[2]

MCbride D.C., Inciardi J.A., Chitwood D.D., McCoy C.B., Crack use and correlates of use in a national population of street heroin users, J Psychoactive Drugs, 24, pp. 411-416, (1992)

[3]

Raymond C.A., Study of IV drug users and AIDS finds differing infection rate, risk behaviors, JAMA, 260, (1988)

[4]

Koblin B.A., McCusker J., Lewis B.F., Sullivan J.L., Racial/ethnic differences in HIV-1 seroprevalence and risky behaviors among intravenous drug users in a multisite study, Am J Epidemiol, 132, pp. 837-846, (1990)

[5]

Des Jarlais D.C., Friedman S.R., HIV infection among persons who inject illicit drugs: Problems and prospects, J Acquir Immune Defic Syndr, 1, pp. 267-273, (1988)

[6]

Chaisson R.E., Bacchetti P., Osmond D., Brodie B., Sande M.A., Moss A.R., Cocaine use and HIV infection in intravenous drug users in San Francisco [see Comments], JAMA, 261, pp. 561-565, (1989)

[7]

Chaisson R.E., Moss A.R., Onishi R., Osmond D., Carlson J.R., Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco, Am J Public Health, 77, pp. 169-172, (1987)

[8]

Brown B.S., Hickev J.E., Chung A.S., Craig R.D., Jatte J.H., The functioning of individuals on a drug abuse treatment waiting list, Am J Drug Alcohol Abuse, 15, pp. 261-274, (1989)

[9]

Fullilove M.T., Fullilove R.E., Intersecting epidemics: Black teen crack use and sexuallv transmitted disease, J am Med Worn Assoc, 44, pp. 146-147, (1989)

[10]

Fullilove R.E., Fullilove M.T., Bowser B.P., Bowser S.A., Risk of sexuallv transmitted disease among black adolescent crack users in Oakland and San Francisco, Calif (see Comments), JAMA, 263, pp. 851-855, (1990)

← 1 2 3 4 →